Comparative effect of ACE inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: Role of superoxide dismutase

Circulation

Volumn 103, Issue 6, 2001, Pages 799-805

  Hornig, Burkhard ^a   Landmesser, Ulf ^a   Kohler, Christoph ^a   Ahlersmann, Dorothe ^a   Spiekermann, Stephan ^a   Christoph, Annemarie ^a   Tatge, Helma ^a   Drexler, Helmut ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Angiotensin; Coronary disease; Endothelium; Inhibitors; Superoxide dismutase

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ASCORBIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN RADICAL; RAMIPRIL; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; BIOAVAILABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIUM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT OUTCOME; VASODILATATION;

EID: 0035852775     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.6.799     Document Type: Article

References (35)

1. Endothelial dysfunction: Clinical implication
2. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
3. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease
4. Effects of an angiotensin-converting inhibitor, ramipril, on death from cardiovascular causes,myocardial infarction, and stroke in high risk patients
5. Randomised trial of losartan versus captopril in patients over 65 with heart failure
6. Effect of selective angiotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo: Intravascular two-dimensional and Doppler ultrasound studies
7. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: Evidence for the involvement of the renin-angiotensin system
8. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)
9. Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis
10. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease
11. Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: Relation to endothelium-dependent vasodilation
12. Regulation of extracellular superoxide dismutase by nitric oxide in vascular smooth muscle
13. Differential effects of quinaprilat and enaprilat on endothelial function of conduit arteries in patients with chronic heart failure
14. Non-invasive estimate of the mechanical properties of peripheral arteries from ultrasonic and photoplethysmographic measurements
15. Physical training improves endothelial function in patients with chronic heart failure
16. Role of bradykinin in mediating vascular effects of ACE-inhibitors in humans
17. Vitamin C improves endothelial function in patients with chronic heart failure
18. Heparin-induced release of extracellular superoxide dismutase to human blood plasma
19. Heparin-induced release of extracellular-superoxide dismutase form (V) to plasma
20. Effect of venous stasis and physical exercise on plasma extracellular superoxide dismutase
21. Reevaluation of assay methods and establishment of kit for superoxide dismutase activity
22. Superoxide dismutase An enzymatic function for erythrocuprein (hemocuprein)
23. Extracellular superoxide dismutase in human tissues and human cell lines
24. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease
25. Plasma α-tocopherol and coronary endothelium-dependent vasodilator function
26. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
27. The interstitium of the human arterial wall contains very large amounts of extracellular Superoxide dismutase
28. Extracellular superoxide dismutase in vessels and airways of humans and baboons
29. Inhibition of coronary artery superoxide dismutase attenuates endothelium-dependent and -independent nitrovasodilator relaxation
30. Angiotensin II type 2 overexpression activates the vascular kinin system and causes vasodilation
31. 2 kinin receptor within the plasma membrane of native endothelial cells
32. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism
33. The interaction of nitric oxide, bradykinin, and the angiotensin II type 2 receptor: Lessons learned from transgenic mice
34. Renal effects of angiotensin II receptor blockade in normotensive subjects
35. Effects of eprosartan and losartan on uric acid metabolism in patients with essential hypertension